Astrid Konrad

1.9k total citations
26 papers, 1.3k citations indexed

About

Astrid Konrad is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Astrid Konrad has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 12 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Astrid Konrad's work include Inflammatory Bowel Disease (12 papers), Gut microbiota and health (4 papers) and Probiotics and Fermented Foods (3 papers). Astrid Konrad is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Gut microbiota and health (4 papers) and Probiotics and Fermented Foods (3 papers). Astrid Konrad collaborates with scholars based in Germany, Switzerland and United States. Astrid Konrad's co-authors include Burkhard Göke, Stephan Brand, Thomas Ochsenkühn, Peter Lohse, Frank Seibold, Yingzi Cong, Charles O. Elson, Jürgen Glas, Julia Diegelmann and Silke Schmechel and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Astrid Konrad

26 papers receiving 1.3k citations

Peers

Astrid Konrad
Anders Dige Denmark
George P. Christophi United States
A. Morali France
Colette Deslandres Canada
Aito Ueno Canada
Lawrence J. Saubermann United States
Geoffrey S. Nash United States
Marie Carlson Sweden
Makoto Shioya Japan
H. Lochs Germany
Anders Dige Denmark
Astrid Konrad
Citations per year, relative to Astrid Konrad Astrid Konrad (= 1×) peers Anders Dige

Countries citing papers authored by Astrid Konrad

Since Specialization
Citations

This map shows the geographic impact of Astrid Konrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Konrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Konrad more than expected).

Fields of papers citing papers by Astrid Konrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Konrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Konrad. The network helps show where Astrid Konrad may publish in the future.

Co-authorship network of co-authors of Astrid Konrad

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Konrad. A scholar is included among the top collaborators of Astrid Konrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Konrad. Astrid Konrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Török, Helga‐Paula, Astrid Konrad, Martin Lacher, et al.. (2017). Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel disease. PLoS ONE. 12(4). e0175180–e0175180. 11 indexed citations
2.
Cong, Yingzi, Lanfang Wang, Astrid Konrad, Trenton R. Schoeb, & Charles O. Elson. (2009). Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine‐protective regulatory T cells. European Journal of Immunology. 39(11). 3134–3146. 78 indexed citations
3.
Lehrke, Michael, Astrid Konrad, Cornelia Tillack, et al.. (2008). CXCL16 is a surrogate marker of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 43(3). 283–288. 27 indexed citations
4.
Schmechel, Silke, Astrid Konrad, Julia Diegelmann, et al.. (2007). Linking genetic susceptibility to Crohnʼs disease with Th17 cell function: IL-22 serum levels are increased in Crohnʼs disease and correlate with disease activity and IL23R genotype status. Inflammatory Bowel Diseases. 14(2). 204–212. 165 indexed citations
5.
Seiderer, Julia, Julia Dambacher, Simone Pfennig, et al.. (2007). The role of the selenoprotein S (SELS) gene −105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens. 70(3). 238–246. 33 indexed citations
6.
Seiderer, Julia, Julia Diegelmann, Jürgen Glas, et al.. (2007). Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflammatory Bowel Diseases. 14(4). 437–445. 279 indexed citations
7.
Konrad, Astrid, Michael Lehrke, Frank Seibold, et al.. (2007). Resistin is an inflammatory marker of inflammatory bowel disease in humans. European Journal of Gastroenterology & Hepatology. 19(12). 1070–1074. 121 indexed citations
8.
Dambacher, Julia, Julia Seiderer, Astrid Konrad, et al.. (2006). The +1059G/C polymorphism in the C‐reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 24(7). 1105–1115. 33 indexed citations
9.
Dambacher, Julia, Julia Seiderer, Fabian Schnitzler, et al.. (2006). Macrophage migration inhibitory factor (MIF) −173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases. 13(1). 71–82. 42 indexed citations
10.
Konrad, Astrid, et al.. (2006). Tight Mucosal Compartmentation of the Murine Immune Response to Antigens of the Enteric Microbiota. Gastroenterology. 130(7). 2050–2059. 67 indexed citations
11.
Cong, Yingzi, Astrid Konrad, Nuzhat Iqbal, et al.. (2005). Generation of Antigen-Specific, Foxp3-Expressing CD4+ Regulatory T Cells by Inhibition of APC Proteosome Function. The Journal of Immunology. 174(5). 2787–2795. 36 indexed citations
12.
Brand, Stephan, Astrid Konrad, Alexander Crispin, et al.. (2005). The Role of Toll-like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms and CARD15/NOD2 Mutations in the Susceptibility and Phenotype of Crohnʼs Disease. Inflammatory Bowel Diseases. 11(7). 645–652. 130 indexed citations
13.
Brand, Stephan, Julia Dambacher, Fabian Schnitzler, et al.. (2005). Increased Expression of the Chemokine Fractalkine in Crohn's Disease and Association of the Fractalkine Receptor T280M Polymorphism with a Fibrostenosing Disease Phenotype. The American Journal of Gastroenterology. 101(1). 99–106. 84 indexed citations
14.
Konrad, Astrid, et al.. (2004). Ameliorative effect of IDS�30, a stinging nettle leaf extract, on chronic colitis. International Journal of Colorectal Disease. 20(1). 9–17. 23 indexed citations
15.
Seibold, Frank, Astrid Konrad, Beatrice Flogerzi, et al.. (2004). Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn’s disease. Gastroenterology. 127(4). 1076–1084. 47 indexed citations
16.
Elson, Charles O., Astrid Konrad, Yingzi Cong, & Casey T. Weaver. (2004). Gene Disruption and Immunity in Experimental Colitis. Inflammatory Bowel Diseases. 10. S25–S28. 8 indexed citations
17.
Konrad, Astrid, Michael Mähler, Beatrice Flogerzi, et al.. (2003). Amelioration of Murine Colitis by Feeding a Solution of LysedEscherichia coli. Scandinavian Journal of Gastroenterology. 38(2). 172–179. 26 indexed citations
18.
Konrad, Astrid & Frank Seibold. (2003). Response of cutaneous Crohn’s disease to infliximab and methotrexate. Digestive and Liver Disease. 35(5). 351–356. 30 indexed citations
19.
Cong, Yingzi, Astrid Konrad, Nuzhat Iqbal, & Charles O. Elson. (2003). Probiotics and Immune Regulation of Inflammatory Bowel Diseases. Current Drug Targets - Inflammation & Allergy. 2(2). 145–154. 24 indexed citations
20.
Göke, Burkhard, et al.. (2002). Das Inkretinhormon GLP-1: Eine therapeutische Option bei Typ-2-Diabetes?. Pharmazie in unserer Zeit. 31(3). 294–299. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Dige Breakdown of academic impact, for papers by George P. Christophi Breakdown of academic impact, for papers by A. Morali Breakdown of academic impact, for papers by Colette Deslandres Breakdown of academic impact, for papers by Aito Ueno Breakdown of academic impact, for papers by Lawrence J. Saubermann Breakdown of academic impact, for papers by Geoffrey S. Nash Breakdown of academic impact, for papers by Marie Carlson Breakdown of academic impact, for papers by Makoto Shioya Breakdown of academic impact, for papers by H. Lochs
Rankless by CCL
2026